Quality assessment of sarcoma care in Europe and Latin America
Official title: Observational Study, for Quality Assessment, of Sarcoma As a Model to Improve Diagnosis and Clinical Care of Rare Tumors Through a European and Latin American Multidisciplinary NETWORK
Run by Grupo Espanol de Investigacion en Sarcomas · NCT04181970 · Data updated 2026-11-12
This study looks at how well patients with different types of sarcoma are treated in Europe and Latin America to see if care is better at expert centers and to find ways to improve outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 120 Years |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | Grupo Espanol de Investigacion en Sarcomas Academic / other |
| Locations | 9 sites (Buenos Aires and 8 other locations) |
| Status | Recruiting |
| Started | June 30, 2019 |
| Main results expected | September 30, 2026 |
| Study ends | September 30, 2026 |
| Registry record updated | March 21, 2025 |
| Trial ID | NCT04181970 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with a histological diagnosis of soft-tissue sarcoma, gastrointestinal stromal tumor, or bone sarcoma.
✕Probably not a fit
Patients with sarcomas diagnosed before January 2005 or those without available clinical and treatment information may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the quality of care for patients with soft-tissue sarcoma, gastrointestinal stromal tumors, and bone sarcoma across expert and non-expert centers. It involves both retrospective and prospective data collection, analyzing various quality indicators and patient outcomes such as survival rates and treatment efficacy. The study also includes a translational research component, utilizing tumor samples to identify biomarkers and develop preclinical models. The goal is to enhance the understanding of treatment differences and improve patient prognosis in sarcoma care.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment protocols and outcomes for sarcoma patients.
How similar studies have gone: Previous studies have shown positive outcomes in sarcoma management when patients are treated at expert centers, supporting the relevance of this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Histological diagnosis of soft-tissue sarcoma, GIST or bone sarcoma (all subtypes) from January 2005 until Juny/September 2023. * ≥ 18 years * Available clinical and treatment information Exclusion Criteria: There is no exclusion criteria
Where it's running
-
A C Camargo
São Paulo, Brazil Recruiting -
Centre Leon Berard
Lyon, France Recruiting -
Instituto Ortopedico Rizzoli
Bologna, Italy Recruiting -
Insituto Nazionale Di Tumore
Milan, Italy Recruiting -
Instituto Nacional de Cancerología
Mexico City, Mexico Recruiting -
Instituo Nacional de enfermedades Neoplásicas
Surquillo, Peru Recruiting
Show 3 more locations
-
Fundación Jiménez Díaz
Madrid, Madrid, Spain Recruiting -
Alexander Fleming Sa
Buenos Aires, Argentina Not yet recruiting -
Hospital San Vicente de Paúl
Heredia, Costa Rica Not yet recruiting
Study contacts
- Principal investigator: Javier MARTIN-BROTO, MD — Salud de Madrid
- Study coordinator: Marta Martin
- Email: martamartinruiz@atbsarc.org
- Phone: +34 910908102
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Preoperative Immunonutrition for bone and soft tissue sarcoma patients
This study tests whether a short course of an oral nutrition supplement before surgery can help patients with bone or soft tissue sarcomas recover better after major tumor-related surgery.
-
Using a special dye to guide surgery for sarcoma removal
This study is testing whether a special dye can help surgeons remove sarcomas more accurately by showing them where the cancer ends during surgery.
-
Assessing early psychiatric referral effects on mental health in sarcoma patients
This study tests whether getting early mental health support helps sarcoma patients feel less anxious and depressed while recovering from surgery.
-
Evaluating quality of life and functional outcomes in sarcoma patients after limb salvage surgery
This study looks at how limb salvage surgery affects the quality of life and daily functioning of people aged 18 to 95 who have had surgery for bone or soft tissue sarcoma in their legs.
-
New method to deliver chemotherapy directly into the lungs for sarcoma patients
This study is testing a new way to deliver chemotherapy directly into the lungs during surgery for sarcoma patients to see if it can better target hidden cancer cells and improve their outcomes.
-
68Ga-HX01 PET/CT Imaging in Soft Tissue Sarcoma patients
This study tests whether a 68Ga-HX01 injection can help PET/CT imaging better characterize soft tissue sarcoma in adults who have exhausted standard treatments or have no good options.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.